<DOC>
	<DOCNO>NCT02972918</DOCNO>
	<brief_summary>The purpose study evaluate whether preoperative optimization levosimendan heart failure patient undergo hip fracture surgery improve haemodynamic tissue perfusion parameter .</brief_summary>
	<brief_title>Preoperative levosimend√°n Hip Fracture</brief_title>
	<detailed_description>Hip fracture predominant entity elderly patient one frequent cause admission hospital . Elderly patient undergo surgery hip fracture high risk morbidity mortality postoperative . Several study show high risk cardiovascular complication group patient 3-months mortality 15-20 % . One cause high morbidity mortality high incidence chronic cardiac failure patient . The goal present study evaluate optimization preoperative cardiac function levosimendan patient leave ventricular ejection fraction &lt; 45 % improve haemodynamic tissue perfusion value , reduce cardiac morbidity mortality 3 month postoperatively . Following write consent , patient leave ventricular ejection fraction &lt; 45 % admit resuscitation anaesthesia room receive levosimendan intravenous injection undergo strict haemodynamic vigilance . Before levosimendan intravenous injection patient firs echocardiography evaluate myocardial function , NT-proBNP . Subsequently , arterial line insert optimization achieve use arterial line connect ProAQT sensor system ( PULSION , Edwards ) . The system use pulse wave analysis assess several parameter include : stroke volume index ( SVI ) , cardiac index ( CI ) , systemic vascular resistance index ( SVRI ) , cardiac power index ( CPI ) .The levosimendan administer like continue injection 24 hour ( 0,1 mcg/kg/min ) without initial dose . Following optimization patient transfer operate room next 3 day come back resuscitation anaesthesia room stay 24 hour complication . All cardiac complication document follw-up do 30 day 3 month postoperative . The patient select 24 month .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>1 . Patients due undergo urgent hip fracture . 2 . Patients cardiac failure ( EF &lt; 45 % ) . 3 . Decompensated heart failure . 4 . Informed consent provide patient . 1 . &lt; 18 year old 2 . Emergency surgery 3 . Serious aortic stenosis ( &lt; 1 cm2 ) 4 . Sustained ventricular tachycardia atrial fibrillation &gt; 140 5 . Earlier episode `` torsades depointes '' 6 . Systolic blood pressure &lt; 85 mmHg 7 . Serious kidney failure ( GFR &lt; 30 ml/min ) 8 . Serious liver failure ( know class C ChildPugh score ) 9 . Allergy levosimendan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>